First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis

Overview of attention for article published in Frontiers in oncology, December 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

ALCASE Italia - Per la Lotta al Cancro del Polmone, 27 Dec 2020

Siamo ormai tutti convinti che anche per il trattamento del microcitoma l’immunochemioterapia è lo standard di cura. Ciò per…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.